(Q40036864)

16 September 2017

Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyalgia? (English)

1 reference

16 September 2017

0 references

Eric Serra

1

0 references

publication date

14 October 2008

1 reference

Nature Clinical Practice Neurology

16 September 2017

1 reference

16 September 2017

4

1 reference

16 September 2017

594-595

1 reference

16 September 2017

11

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

16 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0936

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0936

1 reference

16 September 2017

1 reference

PubMed ID

18852724